Chang HT - Search Results

1

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.

Saura C, Oliveira M, Feng YH, Dai MS, Chen SW, Hurvitz SA, Kim SB, Moy B, Delaloge S, Gradishar W, Masuda N, Palacova M, Trudeau ME, Mattson J, Yap YS, Hou MF, De Laurentiis M, Yeh YM, Chang HT, Yau T, Wildiers H, Haley B, Fagnani D, Lu YS, Crown J, Lin J, Takahashi M, Takano T, Yamaguchi M, Fujii T, Yao B, Bebchuk J, Keyvanjah K, Bryce R, Brufsky A; NALA Investigators. Saura C, et al. Among authors: chang ht. J Clin Oncol. 2020 Sep 20;38(27):3138-3149. doi: 10.1200/JCO.20.00147. Epub 2020 Jul 17. J Clin Oncol. 2020. PMID: 32678716 Free PMC article. Clinical Trial.

2

Predicting two-year quality of life after breast cancer surgery using artificial neural network and linear regression models.

Shi HY, Tsai JT, Chen YM, Culbertson R, Chang HT, Hou MF. Shi HY, et al. Among authors: chang ht. Breast Cancer Res Treat. 2012 Aug;135(1):221-9. doi: 10.1007/s10549-012-2174-6. Epub 2012 Jul 27. Breast Cancer Res Treat. 2012. PMID: 22836876

3

Breast cancer surgery volume-cost associations: hierarchical linear regression and propensity score matching analysis in a nationwide Taiwan population.

Shi HY, Chang HT, Culbertson R, Chen YJ, Liao YC, Hou MF. Shi HY, et al. Among authors: chang ht. Surg Oncol. 2013 Sep;22(3):178-83. doi: 10.1016/j.suronc.2013.05.004. Epub 2013 Jun 21. Surg Oncol. 2013. PMID: 23796402 Review.

4

Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Breast Cancer with Liver-predominant Metastatic Disease.

Hsiao JH, Chang HT, Tseng YD, Chiang CL, Chen IS, Chen YC, Chang PM, Wang BW. Hsiao JH, et al. Among authors: chang pm, chang ht. In Vivo. 2018 Nov-Dec;32(6):1635-1641. doi: 10.21873/invivo.11425. In Vivo. 2018. PMID: 30348727 Free PMC article.

5

Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study.

Huang CS, Yu AL, Tseng LM, Chow LWC, Hou MF, Hurvitz SA, Schwab RB, L Murray J, Chang HK, Chang HT, Chen SC, Kim SB, Hung JT, Ueng SH, Lee SH, Chen CC, Rugo HS. Huang CS, et al. Among authors: chang hk, chang ht. J Immunother Cancer. 2020 Jul;8(2):e000342. doi: 10.1136/jitc-2019-000342. J Immunother Cancer. 2020. PMID: 32718986 Free PMC article. Clinical Trial.

6

Machine Learning Algorithms to Predict Recurrence within 10 Years after Breast Cancer Surgery: A Prospective Cohort Study.

Lou SJ, Hou MF, Chang HT, Chiu CC, Lee HH, Yeh SJ, Shi HY. Lou SJ, et al. Among authors: chang ht. Cancers (Basel). 2020 Dec 17;12(12):3817. doi: 10.3390/cancers12123817. Cancers (Basel). 2020. PMID: 33348826 Free PMC article.

7

Breast Cancer Surgery 10-Year Survival Prediction by Machine Learning: A Large Prospective Cohort Study.

Lou SJ, Hou MF, Chang HT, Lee HH, Chiu CC, Yeh SJ, Shi HY. Lou SJ, et al. Among authors: chang ht. Biology (Basel). 2021 Dec 29;11(1):47. doi: 10.3390/biology11010047. Biology (Basel). 2021. PMID: 35053045 Free PMC article.

8

Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.

Chou CP, Wu MT, Chang HT, Lo YS, Pan HB, Degani H, Furman-Haran E. Chou CP, et al. Among authors: chang ht. Acad Radiol. 2007 May;14(5):561-73. doi: 10.1016/j.acra.2007.02.005. Acad Radiol. 2007. PMID: 17434070

9

Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients.

Pan HJ, Chang HT, Lee CH. Pan HJ, et al. Among authors: chang ht. J Formos Med Assoc. 2016 Jun;115(6):411-7. doi: 10.1016/j.jfma.2015.05.006. Epub 2015 Jun 11. J Formos Med Assoc. 2016. PMID: 26071793 Free article.

10

CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient.

Chen YC, Li HY, Liang JL, Ger LP, Chang HT, Hsiao M, Calkins MJ, Cheng HC, Chuang JH, Lu PJ. Chen YC, et al. Among authors: chang ht. Oncotarget. 2017 May 2;8(18):29699-29710. doi: 10.18632/oncotarget.10719. Oncotarget. 2017. PMID: 27447863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

971 results

Search Page